MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, OSUR made $27,925K in revenue. -$22,377K in net income. Net profit margin of -80.13%.

Income Overview

Revenue
$27,925K
Net Income
-$22,377K
Net Profit Margin
-80.13%
EPS
-$0.32
Unit: Thousand (K) dollars
Revenue Breakdown
    • Hiv
    • Molecular Products
    • Hcv
    • Others
Revenue Breakdown
    • US
    • Africa
    • Europe
    • Other Foreign Countries
Revenue Breakdown
    • cost of products and services so...
    • gross profit

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
27,925 26,763 27,085 31,242
Cost of products and services sold
16,121 15,795 15,313 18,083
Gross profit
11,804 10,968 11,772 13,159
Research and development
13,654 11,418 10,106 11,401
Sales and marketing
6,770 6,584 6,299 6,375
General and administrative
14,556 9,818 11,081 12,676
Loss on impairments
-0 0 0
Change in the estimated fair value of acquisition-related contingent consideration
93 2,983 376 733
Loss on sale of assets
0 -268 0 0
Total operating expenses
35,073 31,071 27,862 31,185
Operating loss
-23,269 -20,103 -16,090 -18,026
Other income
1,548 1,671 2,799 1,135
Loss before income taxes and equity investment
-21,721 -18,432 -13,291 -16,891
Income tax benefit
-432 210 47 2,000
Loss before equity investment
-21,289 -18,642 -13,338 -18,891
Loss on equity investment
-1,088 -644 -374 -802
Net loss
-22,377 -19,286 -13,712 -19,693
Basic EPS
-0.32 -0.27 -0.19 -0.26
Diluted EPS
-0.32 -0.27 -0.19 -0.26
Basic Average Shares
69,675,000 71,528,000 73,004,000 74,541,000
Diluted Average Shares
69,675,000 71,528,000 73,004,000 74,541,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$22,377K (-39.51%↓ Y/Y)Hiv$13,019K (0.92%↑ Y/Y)Molecular Products$9,058K (-0.57%↓ Y/Y)Hcv$2,663K (-38.54%↓ Y/Y)Other Product AndServices Revenues$1,618K (109.31%↑ Y/Y)COVID19$18K (-96.10%↓ Y/Y)Loss before equityinvestment-$21,289K Loss on equityinvestment-$1,088K (-107.63%↓ Y/Y)Income tax benefit-$432K (5.26%↑ Y/Y)Sales$26,376K (-9.04%↓ Y/Y)Other Income-OtherNon Product...$1,549K (65.85%↑ Y/Y)Loss before incometaxes and equity...-$21,721K (-35.99%↓ Y/Y)Other income$1,548K (-12.94%↓ Y/Y)Total revenue$27,925K (-6.70%↓ Y/Y)Operating loss-$23,269K (-31.09%↓ Y/Y)Gross profit$11,804K (-4.02%↓ Y/Y)Cost of products andservices sold$16,121K (-8.57%↓ Y/Y)Total operatingexpenses$35,073K (16.72%↑ Y/Y)General andadministrative$14,556K (3.22%↑ Y/Y)Research and development$13,654K (42.18%↑ Y/Y)Sales and marketing$6,770K (-1.30%↓ Y/Y)Change in the estimatedfair value of...$93K (-80.54%↓ Y/Y)

ORASURE TECHNOLOGIES INC (OSUR)

ORASURE TECHNOLOGIES INC (OSUR)